Corealis’ world-class facilities are purpose-built to develop and manufacture oral solid dosage (OSD) products.
Corealis strictly adheres to current good manufacturing practices (cGMP) in all operations. The company is compliant with International Council on Harmonisation (ICH) guidelines.
The Corealis Quality Assurance team is made up of experienced scientists. Each of them has a wealth of knowledge in cGMP analytics and manufacturing operations. The company’s quality systems undergo regular review by auditors and qualified quality persons (European QP).
Such a review was recently completed through a comprehensive audit conducted by a QQP auditor. This eliminates the need for repeated audits during European clinical supply manufacturing campaigns.
This streamlined process not only saves time but also reduces the costs passed onto clients.